Benjamin F. Edwards & Company, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 2,980 shares of REGN stock, worth $1.87 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,980

Previous 2,368 25.84%

Holding current value

$1.87 Million

Previous $2.28 Million 37.43%

% of portfolio

0.06%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $540,518 - $655,568	612 Added 25.84%	2,980 $3.13 Million
Q1 2024 Apr 29, 2024	BUY	$902.69 - $993.35 $728,470 - $801,633	807 Added 51.7%	2,368 $2.28 Million
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $249,607 - $283,907	322 Added 25.99%	1,561 $1.37 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $815,706 - $994,667	1,178 Added 1931.15%	1,239 $1.02 Million
Q2 2023 Aug 15, 2023	BUY	$700.03 - $830.35 $40,601 - $48,160	58 Added 1933.33%	61 $44,000
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $84,706 - $91,966	-120 Reduced 97.56%	3 $2,000
Q3 2022 Oct 28, 2022	SELL	$573.97 - $724.32 $6,313 - $7,967	-11 Reduced 8.21%	123 $85,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $55,383 - $74,622	-101 Reduced 42.98%	134 $79,000
Q1 2022 May 04, 2022	SELL	$595.12 - $698.43 $11,902 - $13,968	-20 Reduced 7.84%	235 $164,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $16,304 - $20,129	30 Added 13.33%	255 $161,000
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $18,942 - $22,471	33 Added 17.19%	225 $136,000
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $79,430 - $93,834	-168 Reduced 46.67%	192 $107,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $16,529 - $20,283	37 Added 11.46%	360 $170,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $53,569 - $68,093	112 Added 53.08%	323 $156,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $251,674 - $304,093	-462 Reduced 68.65%	211 $118,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $262,446 - $342,565	532 Added 377.3%	673 $420,000
Q1 2020 May 07, 2020	SELL	$336.18 - $494.43 $17,817 - $26,204	-53 Reduced 27.32%	141 $69,000
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $154,061 - $211,598	-562 Reduced 74.34%	194 $73,000
Q3 2019 Nov 05, 2019	BUY	$273.46 - $318.39 $199,899 - $232,743	731 Added 2924.0%	756 $210,000
Q4 2018 Jan 31, 2019	BUY	$335.82 - $403.04 $8,395 - $10,076	25 New	25 $9,000
Q2 2018 Jul 19, 2018	SELL	$284.6 - $344.99 $14,230 - $17,249	-50 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$358.63 - $469.95 $17,931 - $23,497	50	50 $19,000

Others Institutions Holding REGN

# of Institutions

1,441

Shares Held

88.9M

Call Options Held

1.77M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $67.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Regeneron Pharmaceuticals, Inc. Transaction History